BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
44.86
-0.26 (-0.58%)
At close: Jun 27, 2025, 4:00 PM
44.79
-0.07 (-0.16%)
After-hours: Jun 27, 2025, 6:55 PM EDT

BridgeBio Pharma Market Cap

BridgeBio Pharma has a market cap or net worth of $8.52 billion as of June 27, 2025. Its market cap has increased by 57.07% in one year.

Market Cap
8.52B
Enterprise Value
9.84B
1-Year Change
57.07%
Ranking
Category
Stock Price
$44.86

Market Cap Chart

Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $8.52B, an increase of 156.59%. That is a compound annual growth rate of 17.06%.

History

DateMarket Cap% Change
Jun 18, 20257.60B46.46%
Dec 31, 20245.19B-26.16%
Dec 29, 20237.02B516.56%
Dec 30, 20221.14B-53.61%
Dec 31, 20212.46B-71.83%
Dec 31, 20208.72B101.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 696.15B
Johnson & Johnson 366.71B
Novo Nordisk 331.06B
AbbVie 322.03B
UnitedHealth Group 280.41B
Abbott Laboratories 233.80B
Novartis AG 227.75B
AstraZeneca 220.36B
Market Cap Rankings